These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1356250)
21. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Löscher W; Annies R; Hönack D Eur J Pharmacol; 1993 Oct; 242(3):263-74. PubMed ID: 7904243 [TBL] [Abstract][Full Text] [Related]
22. Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions. Maldonado-Irizarry CS; Kelley AE Psychopharmacology (Berl); 1994 Sep; 116(1):65-72. PubMed ID: 7862932 [TBL] [Abstract][Full Text] [Related]
23. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice. Okuyama S; Imagawa Y; Tomisawa K Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909 [TBL] [Abstract][Full Text] [Related]
24. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. Carlsson M; Carlsson A J Neural Transm; 1989; 75(3):221-6. PubMed ID: 2538557 [TBL] [Abstract][Full Text] [Related]
25. Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Kelley AE; Smith-Roe SL; Holahan MR Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12174-9. PubMed ID: 9342382 [TBL] [Abstract][Full Text] [Related]
26. Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons. O'Neill KA; Carelli RM; Jarvis MF; Liebman JM Pharmacol Biochem Behav; 1989 Dec; 34(4):739-45. PubMed ID: 2560212 [TBL] [Abstract][Full Text] [Related]
27. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways. De Leonibus E; Mele A; Oliverio A; Pert A Neuroscience; 2001; 104(1):105-16. PubMed ID: 11311535 [TBL] [Abstract][Full Text] [Related]
28. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice. Maj J; Rogóz Z; Skuza G Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989 [TBL] [Abstract][Full Text] [Related]
29. Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens. Hamilton MH; De Belleroche JS; Gardiner IM; Herberg LJ Pharmacol Biochem Behav; 1986 Nov; 25(5):943-8. PubMed ID: 2878446 [TBL] [Abstract][Full Text] [Related]
30. Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity. Maj J; Klimek V; Gołembiowska K; Rogóz Z; Skuza G Pol J Pharmacol; 1993; 45(5-6):455-66. PubMed ID: 7912134 [TBL] [Abstract][Full Text] [Related]
31. The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat. Hill MP; Brotchie JM Br J Pharmacol; 1999 Dec; 128(7):1577-85. PubMed ID: 10602339 [TBL] [Abstract][Full Text] [Related]
32. Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat. Pulvirenti L; Berrier R; Kreifeldt M; Koob GF Brain Res; 1994 Nov; 664(1-2):231-6. PubMed ID: 7895034 [TBL] [Abstract][Full Text] [Related]
33. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. Ouagazzal A; Nieoullon A; Amalric M Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978 [TBL] [Abstract][Full Text] [Related]
34. Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Rassnick S; Pulvirenti L; Koob GF Psychopharmacology (Berl); 1992; 109(1-2):92-8. PubMed ID: 1365677 [TBL] [Abstract][Full Text] [Related]
35. NMDA receptors in nucleus accumbens modulate stress-induced dopamine release in nucleus accumbens and ventral tegmental area. Doherty MD; Gratton A Synapse; 1997 Jul; 26(3):225-34. PubMed ID: 9183812 [TBL] [Abstract][Full Text] [Related]
36. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Broderick PA; Olabisi OA; Rahni DN; Zhou Y Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963 [TBL] [Abstract][Full Text] [Related]
37. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats. Tan SE Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625 [TBL] [Abstract][Full Text] [Related]
38. Glutamatergic ionotropic blockade within accumbens disrupts working memory and might alter the endocytic machinery in rat accumbens and prefrontal cortex. Baiardi G; Ruiz AM; Beling A; Borgonovo J; Martínez G; Landa AI; Sosa MA; Gargiulo PA J Neural Transm (Vienna); 2007; 114(12):1519-28. PubMed ID: 17616844 [TBL] [Abstract][Full Text] [Related]
39. The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice. (Rapid communication). Nilsson M; Carlsson ML J Neural Transm (Vienna); 1997; 104(4-5):419-25. PubMed ID: 9295174 [TBL] [Abstract][Full Text] [Related]
40. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Hussain N; Flumerfelt BA; Rajakumar N Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]